Antibiotic Resistance Market
ID: MRFR/HC/7107-HCR
90 Pages
Satyendra Maurya
Last Updated: May 04, 2026
Antibiotic Resistance Market Research Report: Size, Share, Trend Analysis By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, and Combination Therapies), By Disease Outlook: cUTI (Complicated Urinary Tract Infections), CDI (Clostridioides difficile Infection), ABSSSI (Acute Bacterial Skin and Skin Structure Infections), HABP (Hospital-Acquired Bacterial Pneumonia), CABP (Community-Acquired Pneumonia), cIAI (Complicated Intra-Abdominal Infection), BSI (Bloodstream Infection) | Pathogen Outlook: E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium | Drug Class Outlook: Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Cephalosporins, Others | Mechanism of Action Outlook: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others | Distribution Channel Outlook: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies | Regional Outlook: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa - Growth Outlook & Industry Forecast Till 2035